Identification of therapeutic targets of the hijacked super-enhancer complex in EVI1-rearranged leukemiaSandra Kiehlmeier(German Cancer Research Center), Stefan Gröschel(University of Applied Sciences Worms)LeukemiaApril 28, 202110.1038/s41375-021-01235-zCited by 38SaveCiteExport RISWatch citationsRelated PapersIntegration of genomics and histology revises diagnosis and enables effective therapy of refractory cancer of unknown primary with <i>PDL1</i> amplification|Molecular Case Studies|2016|60